Read + Share
. Brief Report: HIV-1 Resistance Analysis of Participants With HIV-1 and Hepatitis
B Initiating Therapy With Bictegravir/Emtricitabine/Tenofovir Alafenamide or
Dolutegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate: A Subanalysis of
ALLIANCE Data J Acquir Immune Defic Syndr 2024;97:202.
PMID: 39250654
|
 |
|
